financetom
Business
financetom
/
Business
/
Amendments to Competition Law to have major implications for big tech companies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amendments to Competition Law to have major implications for big tech companies
Feb 8, 2023 11:27 PM

The government had decided to make far reaching changes to the competition law which could have massive implications for big tech companies. The most important would be the change in the definition of "turnover".

Share Market Live

NSE

According to amendments introduced in the Lok Sabha, turnover would mean the global turnover derived from all products and services by a person or enterprise. This implies, that violations of the anti trust law could attract penalties on the global turnover of the company as opposed to domestic turnover as stated in law currently.

The changes to the Competition Amendment Bill have been introduced in parliament after the Ministry of Corporate Affairs examined recommendations of the parliamentary committee on finance. The government intends to move and pass these amendments in the budget session of parliament. The deal value threshold for M&A cases will be periodically reviewed. The proposed law also says that compensation can also be claimed in settlement cases.

ALSO READ | India's competition regulator may make a big change to clear deals worth $1.3 billion

The new law, once passed by parliament would regulate mergers and acquisitions. Combination deals, FDI proposals and Corporate Insolvency Resolution cases would have to be decided within 150 days as opposed to 210 days currently. Also, the Competition Commission of India (CCI) would have to give a prima facie view within 30 days.

The government, after examination of the parliamentary committee report, has not included the effects doctrine in market dominance cases and IPR defence in Section 4.

"There will be no immunity for internal legal advisors from examination on oath by the Director General. Active participation for hub and spoke cartels has been substituted by participation or intention to participate", said an official.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kohl's Collaborates With WHP Global to Roll Out Babies
Kohl's Collaborates With WHP Global to Roll Out Babies"R"Us Products
Mar 12, 2024
09:53 AM EDT, 03/12/2024 (MT Newswires) -- Kohl's (KSS) said Tuesday it has signed a new partnership with WHP Global, the owner of BabiesRUs, to introduce baby gear, furniture, and other products across the US. Kohl's will launch the first BabiesRUs shops in August, with plans to introduce about 200 stores in the fall this year, the company added. It...
Philips, Amazon Web Services Team Up to Provide Digital Pathology Services
Philips, Amazon Web Services Team Up to Provide Digital Pathology Services
Mar 12, 2024
09:57 AM EDT, 03/12/2024 (MT Newswires) -- Royal Philips (PHG) said Tuesday it is expanding collaboration with Amazon.com's ( AMZN ) Amazon Web Services to provide digital pathology services in the cloud. The project will allow pathology labs to store, manage and analyze data and use digital workflows to improve their productivity, Philips said. The labs will also be able...
GXO Logistics Names Nizar Trigui Chief Technology Officer
GXO Logistics Names Nizar Trigui Chief Technology Officer
Mar 12, 2024
09:49 AM EDT, 03/12/2024 (MT Newswires) -- GXO Logistics ( GXO ) said Tuesday that it has appointed Nizar Trigui to the newly created role of chief technology officer. Trigui most recently served as the chief executive officer of Bridgestone Mobility Solutions, GXO said. Price: 49.04, Change: -0.21, Percent Change: -0.43 ...
Regulus Therapeutics Reports 'Positive' Data From Second Cohort of Kidney Disease Trial -- Shares Rise
Regulus Therapeutics Reports 'Positive' Data From Second Cohort of Kidney Disease Trial -- Shares Rise
Mar 12, 2024
09:55 AM EDT, 03/12/2024 (MT Newswires) -- Regulus Therapeutics ( RGLS ) said Tuesday that the second cohort of patients in the phase 1b study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease showed clear evidence of a mechanistic dose response over placebo. The company said the drug candidate showed a dose-dependent response in increasing levels of urinary polycystin proteins,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved